Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
- 1 January 2007
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 156 (1) , 51-56
- https://doi.org/10.1111/j.1365-2133.2006.07556.x
Abstract
Summary. Background The clinical improvement of hidradenitis suppurativa reported in a small number of patients with antitumour necrosis factor (anti‐TNF)‐α theKeywords
This publication has 14 references indexed in Scilit:
- Etanercept: effective in the management of hidradenitis suppurativaBritish Journal of Dermatology, 2006
- Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's diseaseJournal of Dermatological Treatment, 2005
- Hidradenitis suppurativa: a reviewDermatologic Therapy, 2004
- Infliximab for hidradenitis suppurativaBritish Journal of Dermatology, 2003
- Hidradenitis suppurativa: pathogenesis and managementBritish Journal of Plastic Surgery, 2003
- Morbidity in patients with hidradenitis suppurativaBritish Journal of Dermatology, 2001
- Neutrophil-related Host Response in Hidradenitis Suppurativa: A Pilot Study in Patients with Inactive DiseaseActa Dermato-Venereologica, 2001
- Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patientsArchives of Dermatology, 1988
- Hidradenitis suppurativa: Evidence for a bactericidal defect correctable by cholinergic agonistin vitro andin vivoJournal of Clinical Immunology, 1982
- Host-defense mechanisms in hidradenitis suppurativaArchives of Dermatology, 1977